HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 76 filers reported holding HUMACYTE INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,547 | +6.2% | 30,562 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $84,301 | -3.8% | 29,476 | +3.9% | 0.00% | 0.0% |
| Q1 2023 | $87,666 | +49.4% | 28,371 | +2.0% | 0.00% | – |
| Q4 2022 | $58,671 | +117.3% | 27,806 | +231.9% | 0.00% | – |
| Q3 2022 | $27,000 | 0.0% | 8,378 | +1.4% | 0.00% | – |
| Q2 2022 | $27,000 | – | 8,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| York Capital Management Global Advisors, LLC | 2,291,397 | $16,613,000 | 3.70% |
| Monashee Investment Management LLC | 399,910 | $2,899,000 | 0.72% |
| Endowment Wealth Management, Inc. | 96,618 | $700,000 | 0.71% |
| Gladstone Institutional Advisory LLC | 246,717 | $1,789 | 0.14% |
| Diameter Capital Partners LP | 300,338 | $2,177,000 | 0.13% |
| CenterBook Partners LP | 23,706 | $172,000 | 0.10% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 900,100 | $6,526,000,000 | 0.06% |
| Exos Asset Management LLC | 16,139 | $117,000 | 0.06% |
| Maven Securities LTD | 200,000 | $1,450,000 | 0.04% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 11,000 | $80,000 | 0.04% |